GlassScriptPhysician profile
Christina G Deuber
NPI 1760430219
$1,305.16
in general payments reported to CMS, 2019-2025
19 companies · $310 in 2025
The $310 reported for 2025 was more than what 85% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $242 · 2020: $53.42 · 2021: $164 · 2022: $192 · 2023: $211 · 2024: $133 · 2025: $310.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $654.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $654.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tris Pharma INC | $313.04 | 2019-2025 | Dyanavel Xr |
| Neos Therapeutics, LP | $143.80 | 2019-2025 | Cotempla Xr-Odt |
| Corium, LLC | $126.32 | 2025 | Azstarys |
| Pfizer INC. | $113.35 | 2019-2025 | |
| Ironshore Pharmaceuticals INC. | $105.68 | 2022-2024 | Jornay Pm |
| Cranial Technologies, INC | $73.98 | 2019-2025 | Doc Band |
| Astrazeneca Pharmaceuticals LP | $63.25 | 2023-2025 | Flumist Quadrivalent |
| Sanofi Pasteur INC. | $51.94 | 2021-2023 | |
| Glaxosmithkline, LLC. | $51.03 | 2019-2025 | Bexsero |
| Sanofi-Aventis U.S. LLC | $47.86 | 2025 | |
| Kaleo, INC. | $41.58 | 2019-2022 | |
| Supernus Pharmaceuticals, INC. | $38.70 | 2022-2023 | Qelbree |
| Arbor Pharmaceuticals, INC. | $36.26 | 2019 | |
| Seqirus USA INC | $21.34 | 2022 | |
| Genentech USA, INC. | $18.40 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Verrica Pharmaceuticals INC. | $16.55 | 2024 | Ycanth |
| Aytu Biopharma, INC. | $15.06 | 2024 | Karbinal |
| Adlon Therapeutics L.P. | $14.36 | 2019 | |
| Shire North American Group INC | $12.66 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christina Deuber listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.